Inovio Pharmaceuticals, Inc.INONASDAQ
LOADING
|||
Switch Symbol:
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | -42.62% |
| Q2 2025 | -19.61% |
| Q1 2025 | 27.14% |
| Q4 2024 | 99.92% |
| Q3 2024 | -75049.58% |
| Q2 2024 | 9.16% |
| Q1 2024 | -19.09% |
| Q4 2023 | 27.63% |
| Q3 2023 | 5.59% |
| Q2 2023 | -101.18% |
| Q1 2023 | 5757.85% |
| Q4 2022 | -1412.50% |
| Q3 2022 | 66.67% |
| Q2 2022 | -26.32% |
| Q1 2022 | 25.49% |
| Q4 2021 | -75.86% |
| Q3 2021 | 25.64% |
| Q2 2021 | -44.44% |
| Q1 2021 | -80.00% |
| Q4 2020 | -225.00% |
| Q3 2020 | 114.46% |
| Q2 2020 | -219.23% |
| Q1 2020 | 13.33% |
| Q4 2019 | -30.43% |
| Q3 2019 | 23.33% |
| Q2 2019 | 0.00% |
| Q1 2019 | 11.76% |
| Q4 2018 | -25.93% |
| Q3 2018 | -270.88% |
| Q2 2018 | 79.78% |
| Q1 2018 | -50.00% |
| Q4 2017 | 38.46% |
| Q3 2017 | -200.00% |
| Q2 2017 | 58.06% |
| Q1 2017 | 11.43% |
| Q4 2016 | -25.00% |
| Q3 2016 | -7.69% |
| Q2 2016 | -136.36% |
| Q1 2016 | 56.00% |
| Q4 2015 | -412.50% |